Title: IDEAL Partnership – Improved cardiovascular Disease hEALth service delivery in Australia
Status: In development
Summary: The IDEAL study aims to improve the way doctors manage patients’ risk of cardiovascular disease, including conditions such as heart attack or stroke. This research focuses on the development of a new service to calculate cardiovascular risk and deliver this information to GPs to help them make well-informed treatment decisions around risk management to improve outcomes for their patients.
Title: Metformin Aneurysm Trial
Summary: Metformin Aneurysm Trial is a multicentre, randomised, placebo-controlled trial to assess if 1500 mg of metformin per day will reduce Abdominal Aortic Aneurysm (AAA)-related events in patients with small AAAs who do not have diabetes.
Chief Investigator: Prof Jon Golledge – firstname.lastname@example.org
For more information contact: Sophie Rowbotham, Global Trial Manager – email@example.com